Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems

Clinical trial NCT00626236 · COMPLETED

Trial details

NCT number: NCT00626236
Sponsor: Supernus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity Conduct Disorder

Start date: 2008-10-21
Primary completion: 2009-09-23
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.